Mersana
Mersana Therapeutics is a clinical-stage oncology firm that engages in developing novel cancer drugs.
Business Model:
Revenue: $11.9M
Employees: 51-200
Industries / Tags:
Detailed Mersana Information
Geographic Data
Address: 840 Memorial Dr
City: Cambridge
State: MA
Zip: 02139
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$175M
Raised Total:$289M
Social
Metrics
6,431,732Website Global Rank
1,020Website Monthly Traffic
Twitter Followers
Description
Mersana Therapeutics is a clinical-stage oncology firm that engages in developing novel cancer drugs.
Contact Phone:
+16174980020
Contact Email:
Mersana went public on 6/28/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/28/2017
IPO Valuation:
$339M
Ticker Symbol:
MRSN
IPO Price:
$15/share
Amount Raised:
$75M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
